课题基金 / 基金详情

Can concurrent chemoradiation be delayed by induction chemotherapy to treat stage III NSCLC? a pooled analysis

Can concurrent chemoradiation be delayed by induction chemotherapy to treat stage III NSCLC? a pooled analysis
诱导化疗能否延迟同步放化疗治疗 III 期 NSCLC？
批准号：
324184
负责人：
Garant Aurelie
金额：
$0.07万
依托单位：
McGill University Health Centre
依托单位国家：
加拿大
项目类别：
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-01-01 至 2016-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=324184&lang=en
关键词：
Combined Modality Therapy Induction Chemotherapy Inoperable Lung Cancer Non Small Cell Lung Cancer Radiation Therapy Radiosensitization Sequential Chemoradiotherapy

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Purpose/Objective Standard treatment for inoperable stage 3 NSCLC is concurrent chemo-radiation (CRT). In busy centers, radiation treatment often cannot be started promptly. To prevent delays, a regimen consisting of induction chemotherapy followed by CRT
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金